Cargando…
Non-viral Gene Delivery Methods for Bone and Joints
Viral carrier transport efficiency of gene delivery is high, depending on the type of vector. However, viral delivery poses significant safety concerns such as inefficient/unpredictable reprogramming outcomes, genomic integration, as well as unwarranted immune responses and toxicity. Thus, non-viral...
Autores principales: | Gantenbein, Benjamin, Tang, Shirley, Guerrero, Julien, Higuita-Castro, Natalia, Salazar-Puerta, Ana I., Croft, Andreas S., Gazdhar, Amiq, Purmessur, Devina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711090/ https://www.ncbi.nlm.nih.gov/pubmed/33330428 http://dx.doi.org/10.3389/fbioe.2020.598466 |
Ejemplares similares
-
Nonviral overexpression of Scleraxis or Mohawk drives reprogramming of degenerate human annulus fibrosus cells from a diseased to a healthy phenotype
por: Tang, Shirley, et al.
Publicado: (2023) -
Basal-Like Cell-Conditioned Medium Exerts Anti-Fibrotic Effects In Vitro and In Vivo
por: Khan, Petra, et al.
Publicado: (2022) -
NON-VIRAL REPROGRAMMING OF HUMAN NUCLEUS PULPOSUS CELLS WITH FOXF1 VIA EXTRACELLULAR VESICLE DELIVERY: AN IN VITRO AND IN VIVO STUDY
por: Tang, S., et al.
Publicado: (2021) -
Editorial: Bioengineering and translational research for bone and joint diseases
por: Dou, Yun, et al.
Publicado: (2022) -
Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges
por: Asmamaw Mengstie, Misganaw
Publicado: (2022)